Down-regulation of has-miR-10a, independent of BCR-ABL1 activity, participation in cell growth in CML   49  USF2 a potential target of has-miR-10a and increases cell growth   49. This evidence concerns the gene BCR and chronic myelogenous leukemia, BCR-ABL1 positive.